MYC and glioma: All three high grade lines had highly complex genomic profiles and harboured amplifications and deletions at several known cancer genes dysregulated in paediatric glioma, including CCND1, MYC, CDK4, PIK3CA, CDKN2A/B, and RB1[2], [20]–[23].